Category: Medical Oncology

Home / Medical Oncology
Gettysburg Cancer Center Expands Clinical Trial Resources With Help of OneOncology
Post

Gettysburg Cancer Center Expands Clinical Trial Resources With Help of OneOncology

In an interview with Targeted Oncology™, Statish Shah, MD, the medical director of Gettysburg Cancer Center, discusses the OneOncology partnership in more detail and how it will benefit patients.  Gettysburg Cancer Center has joined OneOncology, allowing the community oncology center to expand services and clinical trial resources to its patients. Small community cancer centers play...

Gettysburg Cancer Center Joins OneOncology Platform
Post

Gettysburg Cancer Center Joins OneOncology Platform

Partnership will Expand Cancer Care Services and Access to Clinical Trials in Central Pennsylvania Gettysburg, PA and Nashville, TN – June 21, 2021 — Gettysburg Cancer Center (GCC), with clinics in Gettysburg and Hanover, PA, will join OneOncology, the national platform for independent community oncology practices, OneOncology announced today. By joining OneOncology, Gettysburg Cancer Center...

Satish Shah, MD, our Medical Director, speaks about Theratechnologies Announces First Patient Dosed in Phase 1 Clinical Trial of TH1902 for Sortilin Positive Solid Tumors.
Post

Satish Shah, MD, our Medical Director, speaks about Theratechnologies Announces First Patient Dosed in Phase 1 Clinical Trial of TH1902 for Sortilin Positive Solid Tumors.

Satish Shah, MD, Medical Director, Gettysburg Cancer Center speaks about Theratechnologies Announces First Patient Dosed in Phase 1 Clinical Trial of TH1902 for Sortilin Positive Solid Tumors.   Watch Video   Link to Article: http://www.globenewswire.com/news-release/2021/03/24/2198364/0/en/Theratechnologies-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-of-TH1902-for-Sortilin-Positive-Solid-Tumors.html Theratechnologies Inc., a biopharmaceutical company focusing on the discovery and commercialization of novel therapies, is pleased to report that the...

Characterization of methylation patterns and other non-genetic biomarkers in lung cancer.
Post

Characterization of methylation patterns and other non-genetic biomarkers in lung cancer.

STUDY SPONSOR: Nucleix, Ltd. STUDY TYPE: Observational STUDY DESIGN:  This is a prospective, single visit, multi-center, observational study aimed to collect blood and clinical data from 800 subjects enrolled to the Cases Cohort and 1200 subjects enrolled to the Control Cohort. Subjects will sign the informed consent form and eligibility will be confirmed by the...

Trends in Cancer Incidence in US Adolescents and Young Adults, 1973-2015
Post

Trends in Cancer Incidence in US Adolescents and Young Adults, 1973-2015

Key Points Question  What are the epidemiological characteristics and trends of cancers in US adolescents and young adults (AYAs) from 1973 to 2015? Findings  In this serial cross-sectional, US population-based study using cancer registry data from 497 452 AYAs, the rate of cancer increased by 29.6% from 1973 to 2015, with kidney carcinoma increasing at the greatest rate....

Plan of Action for Cancer Diagnosis
Post

Plan of Action for Cancer Diagnosis

No one ever wants to be told they have cancer. It is something we all fear and dread. If you have recently been diagnosed with cancer, you are probably experiencing a flood of emotions, and you are probably wondering what’s next. There is no denying that cancer is devastating news, but it does not mean your...

Cancer Mortality Rates Continue to Decline in The U.S.
Post

Cancer Mortality Rates Continue to Decline in The U.S.

Continuing a positive trend for the last two decades, cancer death rates declined again last year. According to annual statistics reported from the American Cancer Society, the cancer death rate for men and women combined has fallen 26% from its peak in 1991. This decline translates to nearly 2.4 million deaths averted during this time...

Cervical Cancer Info Sheet
Post

Cervical Cancer Info Sheet

The American Cancer Society estimates there will be 13,240 new diagnosed cervical cancer cases in the U.S. for 2018. To help increase your chances of preventing it, detecting it early and treating it quickly for a better prognosis if you are diagnosed with it, be sure to get as much cervical cancer info as you...

Early Detection and Treatment May Prevent Cervical Cancer
Post

Early Detection and Treatment May Prevent Cervical Cancer

Each year, an estimated 12,820 women in the United States will be diagnosed with some form of cervical cancer. Approximately 4,200 women die from the disease each year, and more than a quarter of a million women will live with the disease each year. While the numbers can be daunting, when detected early, 91 percent...

Gene Therapy. A New Frontier in Medical Innovation
Post

Gene Therapy. A New Frontier in Medical Innovation

Cancer is a disease that is experienced by young and old and by every economic and social segment of the world populace. At some point in everyone’s life, cancer will affect us individually, a member of our family or one or many of our friends and acquaintances. The American Cancer Society projects there will be...

  • 1
  • 2